Patient No 1

14
Patient No 1 Patient No 1 Baseline Baseline Final Final Follow-Up Follow-Up (7.1mo) (7.1mo) Cyphe Cyphe r r 3.0/3 3.0/3 3 3 Preliminary observations regarding angiographic pattern Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents of restenoses after rapamycin-eluting stents implantation implantation A Colombo, D Orlic, G Stankovic et al. A Colombo, D Orlic, G Stankovic et al. point proximal and distal stent margins, arrow heads point to restenotic site point proximal and distal stent margins, arrow heads point to restenotic site

description

Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantation. A Colombo, D Orlic, G Stankovic et al. Patient No 1. Cypher 3.0/33. Baseline. Final. Follow-Up (7.1mo). - PowerPoint PPT Presentation

Transcript of Patient No 1

Page 1: Patient No 1

Patient No 1Patient No 1

BaselineBaseline FinalFinal Follow-Up (7.1mo)Follow-Up (7.1mo)

Cypher Cypher 3.0/333.0/33

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

Page 2: Patient No 1

Cypher Cypher 2.5/332.5/33

Cypher Cypher 3.0/333.0/33

Cypher Cypher 3.0/183.0/18

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

BaselineBaseline FinalFinal Follow-Up (4.8mo)Follow-Up (4.8mo)Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

Patient No 2Patient No 2

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

OverlappingOverlapping

Page 3: Patient No 1

3

Cypher Cypher 3.0/183.0/18

Cypher Cypher 3.0/183.0/18

Cypher Cypher 3.0/183.0/18

BaselineBaseline FinalFinal Follow-Up (5.3mo)Follow-Up (5.3mo)

Patient No 3Patient No 3

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

OverlappingOverlapping

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 4: Patient No 1

Spinning blade

Pivot

4

Patient No 3Patient No 3

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycine-eluting stents implantationrapamycine-eluting stents implantation

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Still IVUS image at the level of the most severe narrowing showing hyperplasia in the stent

Page 5: Patient No 1

Cypher Cypher 2.5/182.5/18

BaselineBaseline FinalFinal Follow-Up (4.3mo)Follow-Up (4.3mo)

Patient No 4Patient No 4

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 6: Patient No 1

BaselineBaseline FinalFinal Follow-Up (6.2mo)Follow-Up (6.2mo)

Patient No 5Patient No 5

Cypher Cypher 2.5/332.5/33

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 7: Patient No 1

Patient No 6Patient No 6

BaselineBaseline FinalFinal Follow-Up (5.2mo)Follow-Up (5.2mo)

Cypher Cypher 3.0/333.0/33

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 8: Patient No 1

Cypher Cypher 2.5/82.5/8

Cypher Cypher 3.0/183.0/18

Cypher Cypher 3.0/183.0/18

Patient No 7Patient No 7

BaselineBaseline FinalFinal Follow-Up (2.7mo)Follow-Up (2.7mo)

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 9: Patient No 1

BaselineBaseline FinalFinal Follow-Up (5.4mo)Follow-Up (5.4mo)

Patient No 8Patient No 8

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Cypher Cypher 3.0/333.0/33

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 10: Patient No 1

BaselineBaseline FinalFinal Follow-Up (5.4mo)Follow-Up (5.4mo)

Patient No 9Patient No 9

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

Cypher Cypher 2.5/332.5/33

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 11: Patient No 1

5

Cypher Cypher 3.0/333.0/33

Cypher Cypher 3.0/183.0/18

Cypher Cypher 3.0/183.0/18

Cypher Cypher 2.5/332.5/33

Cypher Cypher 3.0/183.0/18

Cypher Cypher 2.5/182.5/18

Cypher Cypher 2.25/82.25/8

BaselineBaseline

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Follow-Up (6.4mo)Follow-Up (6.4mo)

Patient No 10Patient No 10

FinalFinal

Cypher Cypher 2.25/82.25/8

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 12: Patient No 1

BaselineBaseline

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Follow-Up (6.4mo)Follow-Up (6.4mo)

Patient No 11Patient No 11

FinalFinal

Cypher Cypher 2.5/332.5/33

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 13: Patient No 1

BaselineBaseline

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycin-eluting stents implantationrapamycin-eluting stents implantation

Follow-Up (6.4mo)Follow-Up (6.4mo)

Patient No 11Patient No 11

FinalFinal

Cypher Cypher 3.0/333.0/33

Cypher Cypher 2.5/332.5/33

Cypher Cypher 2.5/332.5/33

Cypher Cypher 2.5/332.5/33

Cypher Cypher 2.5/182.5/18

Solid arrows point proximal and distal stent margins, arrow heads point to restenotic siteSolid arrows point proximal and distal stent margins, arrow heads point to restenotic site

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Page 14: Patient No 1

Preliminary observations regarding angiographic pattern of restenoses after Preliminary observations regarding angiographic pattern of restenoses after rapamycine-eluting stents implantationrapamycine-eluting stents implantation

A Colombo, D Orlic, G Stankovic et al.A Colombo, D Orlic, G Stankovic et al.

Patient No 11Patient No 11

Still IVUS images at the level of the most severe narrowing

showing hyperplasia in the stent


Disease network mining · Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient g Assigned diagnosis Medications Ml M2 M3 Laboratory values

Disease network mining · Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient g Assigned diagnosis Medications Ml M2 M3 Laboratory values

-,1~}l!MIWJIdocs.neu.edu.tr/library/6017892964.pdf · update(any patient autobiog. record) 1:nte~ dossier number. yes no notfound yes return to maİnmenu info. ofid search patient

-,1~}l!MIWJIdocs.neu.edu.tr/library/6017892964.pdf · update(any patient autobiog. record) 1:nte~ dossier number. yes no notfound yes return to maİnmenu info. ofid search patient

HEMATOLOGY/ONCOLOGY NEw PATiENT QuEsTiONNAirE · HEMATOLOGY/ONCOLOGY NEw PATiENT QuEsTiONNAirE: surGiCAL/HOsPiTALiZATiON HisTOrY: NO YES PATiENT suBsTANCE usE: ... Leukemia Blood

HEMATOLOGY/ONCOLOGY NEw PATiENT QuEsTiONNAirE · HEMATOLOGY/ONCOLOGY NEw PATiENT QuEsTiONNAirE: surGiCAL/HOsPiTALiZATiON HisTOrY: NO YES PATiENT suBsTANCE usE: ... Leukemia Blood

TRANSFORMING THE DIGITAL PATIENT EXPERIENCE€¦ · No-Shows No-shows impact both the patient and the organization. Patient impacts include health risks, delayed care and poor continuity

TRANSFORMING THE DIGITAL PATIENT EXPERIENCE€¦ · No-Shows No-shows impact both the patient and the organization. Patient impacts include health risks, delayed care and poor continuity

No apologies: intubation of the shocked patient

No apologies: intubation of the shocked patient

SCIENCE CHINA Life Sciences - Home - Springer · 470 Feng, K., et al. Sci China Life Sci May (2016) Vol.59 No.5 Table 1 Patient cinical caracteristicsa) Patient NO. Age (years) Sex

SCIENCE CHINA Life Sciences - Home - Springer · 470 Feng, K., et al. Sci China Life Sci May (2016) Vol.59 No.5 Table 1 Patient cinical caracteristicsa) Patient NO. Age (years) Sex

Patient #1

Patient #1

Assessment of impact of Patient Counselling, … Journal of PharmTech Research ISSN : 0974-4304 Vol.1,No.1,pp 1-21, Jan – March 2009 Assessment of impact of Patient Counselling,

Assessment of impact of Patient Counselling, … Journal of PharmTech Research ISSN : 0974-4304 Vol.1,No.1,pp 1-21, Jan – March 2009 Assessment of impact of Patient Counselling,

demie-journée neuropsy cogmaster 2010 handout · Patient 1 Patient 2 Patient 3. 28 MASTER RECHERCHE EN sciences cognitives Patient 1 Patient 2 ... vert: Connectivitéaugmentée pour

demie-journée neuropsy cogmaster 2010 handout · Patient 1 Patient 2 Patient 3. 28 MASTER RECHERCHE EN sciences cognitives Patient 1 Patient 2 ... vert: Connectivitéaugmentée pour

ORIGINAL PAPER - med.nagoya-u.ac.jp › medlib › nagoya_j_med... · 12 (all patients excluding for No. 12, 13, and 15 patient), 1 (No. 8), and 1 (No. 14) patient, respectively (some

ORIGINAL PAPER - med.nagoya-u.ac.jp › medlib › nagoya_j_med... · 12 (all patients excluding for No. 12, 13, and 15 patient), 1 (No. 8), and 1 (No. 14) patient, respectively (some

S.C.P.M. AYURVEDIC MEDICAL COLLEGE AND HOSPITALannual sr. no monthly sr. no daily sr.no opd no. ipd no. patient name f. / husband name address age sex doctor name 1 1 1 19/g22 19/i1

S.C.P.M. AYURVEDIC MEDICAL COLLEGE AND HOSPITALannual sr. no monthly sr. no daily sr.no opd no. ipd no. patient name f. / husband name address age sex doctor name 1 1 1 19/g22 19/i1

Patient safety and compensation harm · 2019-07-20 · –is an incident which did not reach the patient. •No harm incident: –is an incident which reached a patient but no discernible

Patient safety and compensation harm · 2019-07-20 · –is an incident which did not reach the patient. •No harm incident: –is an incident which reached a patient but no discernible

Staff and Patient Safety Level 1 - Airedale NHS Foundation Trust · 2019. 1. 8. · Disruptive Aggressive & Violent Violence No Injury - Patient On Staff Disruptive Aggressive & Violent

Staff and Patient Safety Level 1 - Airedale NHS Foundation Trust · 2019. 1. 8. · Disruptive Aggressive & Violent Violence No Injury - Patient On Staff Disruptive Aggressive & Violent

NEWSLETTER - Anesthesia Patient Safety Foundation · 2020-02-11 · NEWSLETTER THE OFFICIAL JOURNAL OF THE ANESTHESIA PATIENT SAFETY FOUNDATION APSF.ORG Volume 35, No. 1, 1–32 Circulation

NEWSLETTER - Anesthesia Patient Safety Foundation · 2020-02-11 · NEWSLETTER THE OFFICIAL JOURNAL OF THE ANESTHESIA PATIENT SAFETY FOUNDATION APSF.ORG Volume 35, No. 1, 1–32 Circulation

For Office Use Only: TBC NEW PATIENT INFORMATION Patient … · 2019. 8. 16. · TBC NEW PATIENT INFORMATION . ... Snoring . Yes No Bloody stools . Yes No Stop breathing during sleep

For Office Use Only: TBC NEW PATIENT INFORMATION Patient … · 2019. 8. 16. · TBC NEW PATIENT INFORMATION . ... Snoring . Yes No Bloody stools . Yes No Stop breathing during sleep

P10/1 P11/1 - 3B Scientific · 2. The Patient Care Manikin PRO P10/1 The Patient Care Manikin Basic has no inner organs and is intended for basic care procedures. The Patient Care

P10/1 P11/1 - 3B Scientific · 2. The Patient Care Manikin PRO P10/1 The Patient Care Manikin Basic has no inner organs and is intended for basic care procedures. The Patient Care

Patient and Family Education Odette Cancer Centre ...Issue No. 1 Spring 2011 Patient and Family Education Newsletter Odette Cancer Centre Patient and Family Education Newsletter Do

Patient and Family Education Odette Cancer Centre ...Issue No. 1 Spring 2011 Patient and Family Education Newsletter Odette Cancer Centre Patient and Family Education Newsletter Do

pennsylvania patient safety advisorypatientsafety.pa.gov/ADVISORIES/Documents/200803_home.pdf · Page 2 ©2008 Pennsylvania Patient safety Authority Vol. 5, no. 1—March 2008 Pennsylvania

pennsylvania patient safety advisorypatientsafety.pa.gov/ADVISORIES/Documents/200803_home.pdf · Page 2 ©2008 Pennsylvania Patient safety Authority Vol. 5, no. 1—March 2008 Pennsylvania

No Patient Harmed from Post-op Opoids

No Patient Harmed from Post-op Opoids

P10/1 P11/1 - 3B Scientific · 1. The Patient Care Manikin Basic P11/1 2. The Patient Care Manikin PRO P10/1 The Patient Care Manikin Basic has no inner organs and is intended for

P10/1 P11/1 - 3B Scientific · 1. The Patient Care Manikin Basic P11/1 2. The Patient Care Manikin PRO P10/1 The Patient Care Manikin Basic has no inner organs and is intended for